Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  135 نتائج ل ""Hodgkin Disease""

فلترة النتائج

Publication : european journal of haematology
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC-Dutch late effects cohort-linked data.

  • Authors : Juul SJ; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.; Kicinski M

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/diagnosis

  • Source: European journal of haematology [Eur J Haematol] 2023 Mar; Vol. 110 (3), pp. 243-252. Date of Electronic Publication: 2022 Nov 25.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.

Subjects: Hodgkin Disease*; Humans ; Bleomycin/Bleomycin/Bleomycin/therapeutic use

  • Source: European journal of haematology [Eur J Haematol] 2023 Apr; Vol. 110 (4), pp. 386-395. Date of Electronic Publication: 2022 Dec 28.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).

  • Authors : Gillessen S; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Pluetschow A

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/diagnosis ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/drug therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/pathology

  • Source: European journal of haematology [Eur J Haematol] 2022 Dec; Vol. 109 (6), pp. 728-735. Date of Electronic Publication: 2022 Oct 03.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.

Subjects: Cancer Survivors*/Cancer Survivors*/Cancer Survivors*/statistics & numerical data ; Quality of Life*; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*epidemiology

  • Source: European journal of haematology [Eur J Haematol] 2021 May; Vol. 106 (5), pp. 697-707. Date of Electronic Publication: 2021 Feb 28.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study.

  • Authors : Iannitto E; Department of Oncology, Hematology and BMT Unit, Casa di Cura La Maddalena, Palermo, Italy.; Romano A

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*drug therapy; Adolescent

  • Source: European journal of haematology [Eur J Haematol] 2020 Jun; Vol. 104 (6), pp. 581-587. Date of Electronic Publication: 2020 Mar 13.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

  • Authors : Wagner SM; 3rd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria.; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*drug therapy ; Lymphoma, T-Cell, Peripheral/Lymphoma, T-Cell, Peripheral/Lymphoma, T-Cell, Peripheral/*drug therapy

  • Source: European journal of haematology [Eur J Haematol] 2020 Mar; Vol. 104 (3), pp. 251-258. Date of Electronic Publication: 2020 Jan 10.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town?

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Brentuximab Vedotin/Brentuximab Vedotin/Brentuximab Vedotin/*therapeutic use

  • Source: European journal of haematology [Eur J Haematol] 2019 Sep; Vol. 103 (3), pp. 145-151. Date of Electronic Publication: 2019 Jun 17.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid.

  • Authors : Sindel A; Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.; Taylor T

Subjects: Hematopoietic Stem Cell Mobilization*/Hematopoietic Stem Cell Mobilization*/Hematopoietic Stem Cell Mobilization*/methods; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*complications

  • Source: European journal of haematology [Eur J Haematol] 2019 Aug; Vol. 103 (2), pp. 134-136. Date of Electronic Publication: 2019 Jun 07.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint inhibitors: Feasibility and safety.

  • Authors : Dada R; King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.; College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia.

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

  • Source: European journal of haematology [Eur J Haematol] 2019 Feb; Vol. 102 (2), pp. 150-156. Date of Electronic Publication: 2018 Nov 28.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Long-term follow-up of 2 patients treated with 90 Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

  • Authors : Golstein SC; Department of Hematology, Institut Jules Bordet (ULB), Brussels, Belgium.; Muylle K

Subjects: Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*diagnosis ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy ; Lymphocytes/Lymphocytes/Lymphocytes/*pathology

  • Source: European journal of haematology [Eur J Haematol] 2018 Sep; Vol. 101 (3), pp. 415-417. Date of Electronic Publication: 2018 Jul 04.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  135 نتائج ل ""Hodgkin Disease""